Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Seamless Two-Stage Phase I/II Trial Design With Backfill and Joint Monitoring for Dose Optimization.

Pharmaceutical statistics·2026
Same author

Phase 1/1b study of BCMA-targeting bispecific T-cell engager pavurutamab in relapsed/refractory multiple myeloma.

Blood·2026
Same author

A Constrained Hierarchical Bayesian Model Considering Latent Biomarker Subgroups for Time-To-Event Endpoints in Randomized Phase II Trials.

Pharmaceutical statistics·2026
Same author

Simple imputation method for meta-analysis of survival rates when precision information is missing.

Research synthesis methods·2026
Same author

Multi-armed bandits backfill Bayesian optimal interval design.

Journal of biopharmaceutical statistics·2025
Same author

Statistical Consideration for Event-Free Survival With Cure Rate in Acute Myeloid Leukemia Studies.

Pharmaceutical statistics·2025
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

A generalized Bayesian optimal interval design for dose optimization in immunotherapy.

Qing Xia1, Kentaro Takeda2, Yusuke Yamaguchi2

  • 1Global Biostatistics Science, Amgen Inc, Camarillo, California, USA.

Pharmaceutical Statistics
|January 31, 2024
PubMed
Summary
This summary is machine-generated.

A new dose-finding trial design, gBOIN-ETI, efficiently identifies optimal doses for novel immuno-oncology therapies. It outperforms existing methods by better balancing efficacy, toxicity, and immune response in clinical trials.

Keywords:
Bayesian adaptive dose‐finding designdose optimizationefficacy gradeimmune responsemodel‐assisted designtoxicity grade

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

Related Experiment Videos

Last Updated: Jul 4, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

Area of Science:

  • Oncology
  • Immunology
  • Clinical Trial Design

Background:

  • Developing novel immuno-oncology therapies requires precise dose-finding to balance efficacy and toxicity.
  • Traditional dose-finding methods struggle with the complex dose-outcome relationships in immunotherapy.

Purpose of the Study:

  • To introduce a novel generalized Bayesian optimal interval design for immunotherapy (gBOIN-ETI).
  • To simultaneously consider efficacy, toxicity grades, and immune response for optimal dose identification.

Main Methods:

  • The gBOIN-ETI design is a model-assisted approach for efficient immunotherapy development.
  • Simulations compared gBOIN-ETI's operating characteristics against other oncology dose-finding designs.

Main Results:

  • The gBOIN-ETI design demonstrated superior performance in selecting the correct optimal dose.
  • It also showed a higher percentage of patients allocated to the optimal dose across various trial settings.

Conclusions:

  • The gBOIN-ETI design offers an efficient and effective method for dose-finding in novel immuno-oncology therapies.
  • This design improves upon existing approaches by comprehensively evaluating multiple outcomes.